Stocktoria
OmniAb, Inc. OABI
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2020-10-09
OmniAb, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -369.5% | -282.3% | -203.2% | -45.1% | -102.5% |
| Net margin | -347.0% | -235.1% | -148.2% | -37.8% | -77.8% |
| FCF margin | -198.3% | -157.4% | 2.1% | -35.1% | -28.0% |
| Return on assets | -21.5% | -19.1% | -13.5% | -5.3% | -8.9% |
| Return on equity | -24.3% | -21.6% | -16.1% | -6.5% | -11.5% |
| Current ratio | 4.02 | 4.52 | 4.11 | 4.80 | 1.10 |
| Revenue growth | -29.3% | -22.8% | -42.2% | 70.0% | — |
Source: SEC EDGAR filings · CIK 0001846253 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.